Drug – bio-affecting and body treating compositions – Plant material or plant extract of undetermined constitution...
Reexamination Certificate
2006-08-01
2006-08-01
Leith, Patricia (Department: 1654)
Drug, bio-affecting and body treating compositions
Plant material or plant extract of undetermined constitution...
Reexamination Certificate
active
07083813
ABSTRACT:
Compositions and methods for the treatment of peripheral neural and vascular ailments are disclosed. The method comprises administering a flavonoid compound with antioxidant properties, optionally formulated in a acceptable carrier. This compound or combination of compounds provides significant, effective relief of the symptoms of peripheral neural or vascular ailments. In addition, the compositions, when used according to the methods of the present invention, do not exhibit the severe side effects of many prior art compositions proposed for treatment of these ailments.
REFERENCES:
patent: 4147795 (1979-04-01), Sarges
patent: 4210667 (1980-07-01), Sarges et al.
patent: 4232040 (1980-11-01), Waterbury
patent: 4250097 (1981-02-01), Pfister
patent: 4617187 (1986-10-01), Okuyama et al.
patent: 4627973 (1986-12-01), Moran et al.
patent: 4822816 (1989-04-01), Markham
patent: 5011840 (1991-04-01), Sarges
patent: 5070085 (1991-12-01), Markham
patent: 5550249 (1996-08-01), Della Valle et al.
patent: 5561110 (1996-10-01), Michaelis et al.
patent: 5571441 (1996-11-01), Andon et al.
patent: 5595982 (1997-01-01), Harless
patent: 5614224 (1997-03-01), Womack
patent: 5648083 (1997-07-01), Blieszner et al.
patent: 5665360 (1997-09-01), Mann
patent: 5686082 (1997-11-01), N'Guyen
patent: 5709868 (1998-01-01), Perricone
patent: 5770260 (1998-06-01), Fukuyama et al.
patent: 5776460 (1998-07-01), Kim et al.
patent: 5804168 (1998-09-01), Murad
patent: 5824666 (1998-10-01), Deckner et al.
patent: 5840736 (1998-11-01), Zelle et al.
patent: 5866578 (1999-02-01), Mylari et al.
patent: 5872140 (1999-02-01), Hesse et al.
patent: 5876737 (1999-03-01), Schonrock et al.
patent: 5883086 (1999-03-01), Craft
patent: 5922335 (1999-07-01), Ptchelintasev
patent: 5952391 (1999-09-01), Gers-Barlag et al.
patent: 5958379 (1999-09-01), Regenold et al.
patent: 5972359 (1999-10-01), Sine et al.
patent: 5972999 (1999-10-01), Murad
patent: 5976568 (1999-11-01), Riley
patent: 5976579 (1999-11-01), McLean
patent: 5981594 (1999-11-01), Okamoto et al.
patent: 5998394 (1999-12-01), Voorhees et al.
patent: 6048886 (2000-04-01), Neigut
patent: 6051602 (2000-04-01), Bissett
patent: 6054128 (2000-04-01), Wakat
patent: 6069168 (2000-05-01), Horrobin et al.
patent: 6162801 (2000-12-01), Kita
patent: 6296861 (2001-10-01), Perricone
patent: 6299896 (2001-10-01), Cooper et al.
patent: 6555573 (2003-04-01), Rosenbloom
patent: 6592896 (2003-07-01), Rosenbloom
patent: 6596313 (2003-07-01), Rosenbloom
patent: 07324037 (1995-12-01), None
patent: WO 97/18817 (1997-05-01), None
Rona, Z.: Treating Periperal Neuropathy; Toronto Star, Aug. 2, 1998 pp. 1-2.
Cunningham JJ, “The glucose/insulin system and vitamin C: implications in insulin-dependent diabetes mellitus”,J Am Coll NutrApr. 1998;17(2):105-8 Abstract.
Crabbe MJ, et al., “Aldose reductase: a window to the treatment of diabetic complications?”,Prog Retin Eye ResJul. 1998;17(3):313-83 Abstract.
Fujita T, et al., “Inhibitory effects of perillosides A and C, and related monoterpene glucosides on aldose reductase and their structure-activity relationships”,Chem Pharm Bull(Tokyo) Jun. 1995;43(6):920-6 Abstract.
Eaton RP, et al., “A commentary on 10 years of aldose reductase inhibition for limited joint mobility in diabetes”,J Diabetes ComplicationsJan.-Feb. 1998;12(1):34-8 Abstract.
Costantino L,et al., “Diabetes complications and their potential prevention: aldose reductase inhibition and other approaches”Med Res Rev, Jan. 1999.;19(1):3-23 Abstract.
Benstead TJ, et al., “Nerve microvessel changes in diabetes are prevented by aldose reductase inhibition”,Can J Neurol SciAug. 1995;22(3):192-7 Abstract.
Okada Y, et al., “Search for naturally occuring substances to prevent the complications of diabetes. II. Inhibitory effect of coumarin and flavonoid derivatives on bovine lens aldose reductase and rabbit platelet aggregation”Chem Pharm Bull(Tokyo) Aug. 1995.;43(8):1385-7 Abstract.
Costantino L, et al., “1-Benzopyran-4-one antioxidants as aldose reductase inhibitors”,J Med ChemJun. 3, 1999;42(11):1881-93 Abstract.
Nishimura-Yabe C, “Aldose reductase in the polyol pathway: a potential target for the therapeutic intervention of diabetic complications”Nippon Yakurigaku ZasshiMar.1998;111(3):137-45 Abstract.
Tomlinson DR, et al., “Aldose reductase inhibitors and their potential for the treatment of diabetic complications”Trends Pharmacol SciAug.1994;15(8):293-7 Abstract.
Airey M, et al., “Aldose reductase inhibitors for the prevention and treatment of diabetic peripheral neuropathy”,Cochrane Database Syst Rev2000;(2):CD002182 Abstract.
Maxwell SR, et al., “Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus”,Eur J Clin InvestJun.1997;27(6):484-90 Abstract.
Himmerich S., et al., “Effect of Vitamins E and C on Nitric Oxide Production in Oxidized Low Density Lipoprotein Treated Human Aortic Endothelial Cells”,Academic Press; 2000, internet download at http://www.academicpress.com/www/journal
iox/9204.html.
Asahi K, et al., “Nitric Oxide Inhibits the Formation of Advanced Glycation End Products”,Kidney IntOct.2000; 58(4):1780-7.
“Alternative Therapies for Diabetes” by National Diabetes Information Clearinghouse, May 1999.
Tiukavkima, et al., “Dihydorquercetin—a new antioxidant and biologically active food additive”, Vopr Pitan 1997;(6):12-5 Abstract.
Plumb, et al., “Antioxidant properties of flavonal glycosides from tea”,Redox Rep1999;4(1-2):13-6 Abstract.
Duke, et al., “Biological Activities of CURCUMINOIDS”, Phytochemical and Ethnobotanical Database.
Robak, et al., “Bioactivity of flavonoids”,Pol J PharmacolNov.-Dec.1996;48(6):555-64 Abstract.
Bursel, et al., “Can protein kinase C inhibition and vitamin E prevent the development of diabetic vascularcomplications?”,Diabetes Res Clin PractSep.1999; 45(2-3):169-82.
Freedman, et al., “Select flavonoids and whole juice from purple grapes ihibit platelet function and enhance nitric oxide release”,CirculationJun. 12, 2001; 103(23):2792-8 Abstract.
Lin, et al., “Recent studies on the biofunctions and biotransformations of curcumin”,Biofctors2000;13(1-4):153-8 Abstract.
Duarte, et al., “Vasodilator effects of quercetin in isolated rat vascular smooth muscle”,Eur J PharmacolAug. 1993, 239:1-7 Abstract.
Giugliano, et al., “Oxidative stress and diabetic vascular complications”,Diabetes CareMar. 1996;19(3):257-67 Abstract.
Sports Medicine Articles (online), Sep. 1, 2000 (retrieved on Jan. 10, 2002) Retreived from the Internet http://www.rehabnet.com/Sports/Actinic%20Dermatitis.htm, p. 1-2.
Ohguro N, et al., “Topical Aldose reductase inhibitor for correcting corneal endothelial changes in diabetic patients”,Medscape Medline Abstract, Dec. 1995.
Coles, L.S., M.D., “Quercetin:A Review of Clinical Applications”,Natural Medicine Online, pp. 1-5.
Singh J.P., et al., “Role of Nitric Oxide in Pain”,Academic Press 2000.
Kuroda, R., et al., “The Neuronal NO Synthase Inhibitor 7-nitro-indazole facilitates the antinociception elicited by the electrical stimulation of the secondary somatosensory cortex in the rat”,Academic Press, 2000.
Mitchell, T., “Over-the Counter Drug is Treatment for Alzheimer's”,LE Magazine, Nov. 2000, pp. 1-9.
Ross D, et al., “Ascorbate 6-palmitate-protects human erythrocytes from oxidative damage”,Free Radic Biol MedJan. 1999;26(1-2):81-9.
Medscape Medline Abstract, “Aldose reductase: a window to the treatment of diabetic complications?” by Crabbe MJ and Goode D. Jul. 1998.
Thirugnanasambantham P, et al., “Analgesic activity of certain flavone derivatives: a structure-activity study”,Clin Exp Pharmacol PhysiolJan. 1993;20(1):59-63.
Guillausseau P
Knoble & Yoshida & Dunleavy LLC
Leith Patricia
The Quigley Corporation
LandOfFree
Methods for the treatment of peripheral neural and vascular... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods for the treatment of peripheral neural and vascular..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods for the treatment of peripheral neural and vascular... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3705794